Quantification of free circulating tumor DNA as a diagnostic marker for breast cancer

DNA and Cell Biology

Volumn 27, Issue 8, 2008, Pages 415-421

  Catarino, Raquel ^a,b   Ferreira, Maria M ^a   Rodrigues, Helena ^a   Coelho, Ana ^a   Nogal, Ana ^a   Sousa, Abreu ^a   Medeiros, Rui ^a,c  

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c Pessoa University   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; TUMOR MARKER;

ADULT; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST SURGERY; CANCER DIAGNOSIS; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; BLOOD; BREAST TUMOR; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PORTUGAL; PREDICTION AND FORECASTING; REFERENCE VALUE; RISK FACTOR;

ADULT; BREAST NEOPLASMS; DNA; DNA, NEOPLASM; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; PORTUGAL; PREDICTIVE VALUE OF TESTS; REFERENCE VALUES; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 51649092604     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2008.0744     Document Type: Article

References (33)

1. Anker, P., Lefort, F., Vasioukhin, V., Lyautey, J., Lederrey, C., Chen, X.Q., Stroun, M., Mulcahy, H.E., and Farthing, M.J. (1997). K-ras mutations are found in DNA extracted from the plasma of patients with colorectal cancer. Gastroenterology 112(4), 1114-1120.
2. Anker, P., Mulcahy, H., Chen, X.Q., and Stroun, M. (1999). Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 18(1), 65-73.
3. Baselga, J., and Norton, L. (2002). Focus on breast cancer. Cancer Cell 1(4), 319-322.
4. Chen, X., Bonnefoi, H., Diebold-Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E., Stroun, M., and Anker, P. (1999). Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer. Clin Cancer Res 5(9), 2297-2303.
5. Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L.A., Jr., Goodman, S.N., David, K.A., Juhl, H., Kinzler, K.W., and Vogelstein, B. (2005). Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 102(45), 16368-16373.
6. Esteller, M., Sanchez-Cespedes, M., Rosell, R., Sidransky, D., Baylin, S.B., and Herman, J.G. (1999). Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients. Cancer Res 59(1), 67-70.
7. Fleischhacker, M., and Schmidt, B. (2007). Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 1775(1), 181-232.
8. Frattini, M., Balestra, D., Verderio, P., Gallino, G., Leo, E., Sozzi, G., Pierotti, M.A., and Daidone, M.G. (2005). Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients. J Clin Oncol 23(13), 3163-3164; author reply 3164-3165.
9. Gal, S., Fidler, C., Lo, Y.M., Taylor, M., Han, C., Moore, J., Harris, A.L., and Wainscoat, J.S. (2004). Quantitation of circulating DNA in the serum of breast cancer patients by realtime PCR. Br J Cancer 90(6), 1211-1215.
10. Gautschi, O., Bigosch, C., Huegli, B., Jermann, M., Marx, A., Chasse, E., Ratschiller, D., Weder, W., Joerger, M., Betticher, D.C., Stahel, R.A., and Ziegler, A. (2004). Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 22(20), 4157-4164.
11. Gormally, E., Caboux, E., Vineis, P., and Hainaut, P. (2007). Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635(2-3), 105-117.
12. Heid, C.A., Stevens, J., Livak, K.J., and Williams, P.M. (1996). Real time quantitative PCR. Genome Res 6(10), 986-994.
13. Hibi, K., Robinson, C.R., Booker, S., Wu, L., Hamilton, S.R., Sidransky, D., and Jen, J. (1998). Molecular detection of genetic alterations in the serum of colorectal cancer patients. Cancer Res 58(7), 1405-1407.
14. Huang, Z.H., Li, L.H., and Hua, D. (2006). Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients. Cancer Lett 243(1), 64-70.
15. Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F.O., Hesch, R.D., and Knippers, R. (2001). DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61(4), 1659-1665.
16. Kamangar, F., Dores, G.M., and Anderson, W.F. (2006). Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24(14), 2137-2150.
17. Kopreski, M.S., Benko, F.A., Kwee, C., Leitzel, K.E., Eskander, E., Lipton, A., and Gocke, C.D. (1997). Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76(10), 1293-1299.
18. Lee, T.H., Montalvo, L., Chrebtow, V., and Busch, M.P. (2001). Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 41(2), 276-282.
19. Leon, S.A., Shapiro, B., Sklaroff, D.M., and Yaros, M.J. (1977). Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37(3), 646-650.
20. Lo, Y.M., Zhang, J., Leung, T.N., Lau, T.K., Chang, A.M., and Hjelm, N.M. (1999). Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 64(1), 218-224.
21. Mandel, P., and Métais, P. (1948). Les acides nucléiques du plasma sanguin chez l'homme. CR Acad Sci Paris 142, 241-243.
22. Mao, L., Hruban, R.H., Boyle, J.O., Tockman, M., and Sidransky, D. (1994). Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res 54(7), 1634-1637.
23. Shao, Z.M., Wu, J., Shen, Z.Z., and Nguyen, M. (2001). p53 mutation in plasma DNA and its prognostic value in breast cancer patients. Clin Cancer Res 7(8), 2222-2227.
24. Shapiro, B., Chakrabarty, M., Cohn, E.M., and Leon, S.A. (1983). Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 51(11), 2116-2120.
25. Silva, J.M., Gonzalez, R., Dominguez, G., Garcia, J.M., Espana, P., and Bonilla, F. (1999). TP53 gene mutations in plasma DNA of cancer patients. Genes Chromosomes Cancer 24(2), 160-161.
26. Silva, J.M., Silva, J., Sanchez, A., Garcia, J.M., Dominguez, G., Provencio, M., Sanfrutos, L., Jareno, E., Colas, A., Espana, P., and Bonilla, F. (2002). Tumor DNA in plasma at diagnosis of breast cancer patients is a valuable predictor of disease-free survival. Clin Cancer Res 8(12), 3761-3766.
27. Skvortsova, T.E., Rykova, E.Y., Tamkovich, S.N., Bryzgunova, O.E., Starikov, A.V., Kuznetsova, N.P., Vlassov, V.V., and Laktionov, P.P. (2006). Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation. Br J Cancer 94(10), 1492-1495.
28. Sozzi, G., Conte, D., Leon, M., Ciricione, R., Roz, L., Ratcliffe, C., Roz, E., Cirenei, N., Bellomi, M., Pelosi, G., Pierotti, M.A., and Pastorino, U. (2003). Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21(21), 3902-3908.
29. Sozzi, G., Conte, D., Mariani, L., Lo Vullo, S., Roz, L., Lombardo, C., Pierotti, M.A., and Tavecchio, L. (2001). Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61(12), 4675-4678.
30. Sozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Verderio, P., and Pastorino, U. (2005). Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 97(24), 1848-1850.
31. Wong, I.H., Lo, Y.M., Zhang, J., Liew, C.T., Ng, M.H., Wong, N., Lai, P.B., Lau, W.Y., Hjelm, N.M., and Johnson, P.J. (1999). Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res 59(1), 71-73.
32. Wu, T.L., Zhang, D., Chia, J.H., Tsao, K.H., Sun, C.F., and Wu, J.T. (2002). Cell-free DNA: measurement in various carcinomas and establishment of normal reference range. Clin Chim Acta 321(1-2), 77-87.
33. Ziegler, A., Zangemeister-Wittke, U., and Stahel, R.A. (2002). Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 28(5), 255-271.